Privacy legislation should not amend current IRB regs, PhRMA testifies at House hearing on Condit bill.
Executive Summary
MEDICAL RECORDS PRIVACY LEGISLATION SHOULD NOT AMEND IRB REVIEW REGS, PhRMA maintained at a June 5 hearing of the House Government Reform/Government Management, Information & Technology Subcommittee. Glaxo Wellcome Worldwide Epidemiology Director Elizabeth Andrews testified on behalf of the Pharmaceutical Research & Manufacturers of America at the hearing, which was called by Subcommittee Chairman Rep. Horn (R-Calif.) to discuss privacy legislation introduced by Rep. Condit (D-Calif.) this session as HR 52.